SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-01-502099
Filing Date
2001-07-19
Accepted
2001-07-19 00:00:00
Documents
2
Period of Report
2001-07-13
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b40130ane8-k.txt 8-K 2607
2 PRESS RELEASE DATED, JULY 13, 2001 b40130anex99-1.txt EX-99.1 1194
  Complete submission text file 0000950135-01-502099.txt   5436
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 1684595
SIC: 2836 Biological Products, (No Diagnostic Substances)